why choose us

First received: March 10, 2023

Clinical Trial: Effects of Semaglutide on Intracranial Blood Flow and Brain-Barrier Permeability in Type-2 Diabetes

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Diabetes Mellitus, Type 2

Study Type: INTERVENTIONAL


Official Title: Effects of Semaglutide on Intracranial Blood Flow and Brain-Barrier Permeability in Type-2 Diabetes

Brief Summary: A human subjects research study, the primary purpose of which is to assess the EFFECTS OF SEMAGLUTIDE ON INTRACRANIAL BLOOD FLOW AND BLOOD-BRAIN BARRIER PERMEABILITY IN TYPE-2 DIABETES (T2D) through testing of the intervention on patients in a clinical setting.The study will randomize subjects with diabetes to either semaglutide or matching placebo.Magnetic resonance images will be primary endpoint measured at baseline and at one year to assess effect of this FDA approved medication.Given the available evidence…

Read more